Showing results (1-10 of 1,052) with videos related to

Sort By:
Pageof 106
Clinical Endocrinology|December 1, 1977
Histopathology of renal osteodystrophy with particular reference to the effects of 1alpha-hydroxyvitamin D3 in patients treated by long-term haemodialysisH A Ellis, A M Pierides, T G Feest, et al.
Clinical Nephrology|September 1, 1978
Serum ferritin concentration: a reliable guide to iron overload in uremic and hemodialyzed patientsP Aljama, M K Ward, A M Pierides, et al.
Kidney International|July 1, 1978
Hemodialysis bone disease: correlation between clinical, histologic, and other findingsF Alvarez-Ude, T G Feest, M K Ward, et al.
Lancet (London, England)|May 22, 1976
Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophyA M Pierides, H A Ellis, W Simpson, et al.
British Medical Journal|January 7, 1978
Osteomalacic dialysis osteodystrophy: a trial of phosphate-enriched dialysis fluidT G Feest, M K Ward, H A Ellis, et al.
Clinical Endocrinology|December 1, 1977
The effect of 1alpha-hydroxyvitamin D3 in pre-dialysis renal bone diseaseA M Pierides, H A Ellis, W Simpson, et al.
Lancet (London, England)|April 22, 1978
Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminiumM K Ward, T G Feest, H A Ellis, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1976
Long term therapy with 1,25(OH)2D3 in dialysis bone diseaseA M Pierides, M K Ward, F Alvarez-Ude, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1977
The need and use of a phosphate-enriched dialysate during regular hemodialysisA M Pierides, H A Ellis, M K Ward, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1975
Assessment of renal osteodystrophy following renal transplantationA M Pierides, H A Ellis, K M Peart, et al.
Pageof 106